Navigation Links
Vasogen Complies with NASDAQ Marketplace Rule 4350(c)(1)
Date:1/20/2009

MISSISSAUGA, ON, Jan. 20 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ: VSGN; TSX:VAS) today announced that it received a Nasdaq Staff Deficiency Letter on January 13, 2009, indicating that it no longer complies with Nasdaq's independent director requirement as set forth in Nasdaq Marketplace Rule 4350(c)(1) (the "Rule"). The letter was a result of the resignation of a Director, which was announced publicly in a January 6, 2009 press release. Following the receipt of the letter, the Company informed the Nasdaq that it was availing itself of the Foreign Private Issuer Exemption afforded in Marketplace Rule 4350(a)(1) with respect to the Rule, and as a result, on January 15, 2009, the Company received correspondence from the Nasdaq indicating that it complies with the Rule and that the matter is now closed. Nasdaq regulations require the Company to issue a press release to disclose such matters.

Certain statements in this document constitute "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and/or "forward-looking information" under the Securities Act (Ontario). These statements may include, without limitation, plans to complete a sale, merger, acquisition, or other strategic alternative, statements regarding the status of development, or expenditures relating to the Celacade(TM) System or our VP series of drugs including VP015 and VP025, plans to fund our current activities, statements concerning our partnering activities, health regulatory submissions, strategy, future operations, future financial position, future revenues and projected costs. In some cases, you can identify forward-looking statements by terminology such as "may", "will", "should", "expects", "plans", "anticipates", "believes", "estimated", "predicts", "potential", "continue", "intends", "could", or the negative of
'/>"/>

SOURCE Vasogen Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Vasogen Announces Third Quarter Conference Call and Webcast of Bio InvestorForum 2007 Presentation
2. Vasogen Announces Third Quarter 2007 Results
3. Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences
4. Vasogen Provides an Update on ACCLAIM-II Preparations
5. Vasogen and Grupo Ferrer Announce Initial Roll-out of Celacade - New Therapy for Chronic Heart Failure
6. Vasogen to Conduct Year-end 2007 Conference Call
7. Vasogen Announces 2007 Year-End Results
8. The Lancet Publishes Vasogens ACCLAIM Results
9. Vasogens Research Published in European Journal of Neuroscience
10. Vasogen to Present at the BIO CEO & Investor Conference and Participate on the Non-Cancer Immunotherapy Panel
11. Vasogen Provides Update on ACCLAIM II Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... May 23, 2013 PuraMed BioScience ® ... marketer of over-the-counter (OTC) medicinal and healthcare products, ... on the company based on low market capitalization ... Non-Prescription, All Natural Product to Treat Migraine Headaches ... #1 Prescription Competitor , Currently Available Nationwide ...
(Date:5/23/2013)... MA (PRWEB) May 23, 2013 ... inch wide and provide 15 mm travel range ... The small dimensions make these new positioners ... confined spaces. A vacuum rated version is also ... Drawings, specifications and datasheets can be found at: ...
(Date:5/23/2013)... Virobay, Inc. today announced that their development ... important milestone, as Virobay has now initiated a Phase ... S inhibitor.   The first Phase 1 ... designed to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics ... "The initiation of this Phase 1 trial with ...
(Date:5/23/2013)... 23, 2013 Z Trim Holdings, Inc. (OTC ... a variety of industries, announced that Chef ... at this year,s National Restaurant Association ("NRA") NRA Show, ... of the Research Chefs Association.  Chef Ryan spoke on ... the Bad and the Ugly," joining four other prestigious ...
Breaking Biology Technology:PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3
... Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ) ... developmental product candidate, fidaxomicin, will be presented ... Infectious Disease Society of America (IDSA) to be held ... Canada on October 21-24, 2010. (Logo: ...
... Iceland, October 11, 2010 ... ... var ... by longUrl, so we need to grab the first one. for (var r in data.results) { first_result ...
... 2010 VIB researchers at the University of Antwerp have identified ... of Hereditary Sensory and Autonomous Neuropathy Type 1 (HSAN 1). ... nervous system. Identification of the mutations will lead to a ... as improved genetic counseling and prenatal diagnostic tests for couples ...
Cached Biology Technology:Optimer Pharmaceuticals Announces Presentations at Upcoming IDSA Annual Meeting 2Not Only Size Matters: Genetic Megastudies Draw Out Distinctions Between Obesity and Waist-Hip Ratio 2Not Only Size Matters: Genetic Megastudies Draw Out Distinctions Between Obesity and Waist-Hip Ratio 3Not Only Size Matters: Genetic Megastudies Draw Out Distinctions Between Obesity and Waist-Hip Ratio 4Not Only Size Matters: Genetic Megastudies Draw Out Distinctions Between Obesity and Waist-Hip Ratio 5Not Only Size Matters: Genetic Megastudies Draw Out Distinctions Between Obesity and Waist-Hip Ratio 6Not Only Size Matters: Genetic Megastudies Draw Out Distinctions Between Obesity and Waist-Hip Ratio 7Not Only Size Matters: Genetic Megastudies Draw Out Distinctions Between Obesity and Waist-Hip Ratio 8HSAN 1: Identification of new mutations, more accurate diagnosis and improved genetic counseling 2
(Date:5/24/2013)... scientists have focused among other factors on drugs ... is the accumulation of A-beta that causes the known plaques ... formation of A-beta is APP. Alessia Soldano and Bassem Hassan ... APPL the fruit-fly version of APP in the ... Leuven): "We have discovered that APPL ensures that brain cells ...
(Date:5/24/2013)... scientists from around the world today issued a stark ... of one or two generations, the majority of the ... the handicap of severe pressure on fresh water, an ... substitute. This handicap will be self-inflicted and is, we ... chronic underlying problems led by mismanagement and sent a ...
(Date:5/23/2013)... Plant Science , Automated conserved ... and promoter evolution among grasses , Within the ... of DNA that undergo little change in position and ... for any proteins. Some of these evolutionarily stable sequences, ... the expression of other genes or the condensation of ...
Breaking Biology News(10 mins):A new strategy required in the search for Alzheimer's drugs? 2A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 2A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 3A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 4Frontiers news briefs: May 23 2Frontiers news briefs: May 23 3
... Calif., and PARIS, Nov. 15, 2011 ... of authentication and endpoint protection solutions, today announced ... software for biometric device manufacturers and solution providers. ... template generation along with fast one-to-many identification and ...
... environment and undermining many benefits we rely on from ... stability, according to a team of scientists writing in ... Issues in Ecology . In "Setting Limits: Using ... lead author Mark Fenn (USDA Forest Service) and nine ...
... A $7.5 million award will help researchers harness ... create new types of antidotes for exposure to pesticides ... Institutes of Health (NIH), extends a previous grant and ... University, where chemists will collaborate with the U.S. Army ...
Cached Biology News:DigitalPersona Announces FingerJet OEM Fingerprint Recognition Software for Biometric Device Manufacturers and Solution Providers 2DigitalPersona Announces FingerJet OEM Fingerprint Recognition Software for Biometric Device Manufacturers and Solution Providers 3Using air pollution thresholds to protect and restore ecosystem health 2Using air pollution thresholds to protect and restore ecosystem health 3Researchers get $7.5M grant to combat nerve agents 2Researchers get $7.5M grant to combat nerve agents 3
Sirtuin 7 (SIRT7) Rabbit anti-Human Polyclonal Antibody Immunogen: Synthetic peptide - KLH conjugated Family: Other Recommended Storage: Long term: -20C; Short term: +4C...
... The RSH-4000 is the only microplate sealer ... offers long walkaway times with a variety ... , Fully automated with integrated stacker and ... PlateCrane EX for use in small workcells ...
... of mouse embryonic stem cells to dopaminergic ... midbrain, where they are mainly located in ... and the retrorubral field. These dopaminergic (DA) ... innervation ( e.g.projections to the caudate nucleus, ...
... DNA aptamer screening and binding optimization and ... microfluidic on-chip synthesis platform. Thousands of customer ... LC Sciences can provide assistance with custom ... part of our comprehensive DNA/RNA Aptamer Microarray ...
Biology Products: